Results 11 to 20 of about 1,385,084 (219)

Tumor Restrictions to Oncolytic Virus [PDF]

open access: yesBiomedicines, 2014
Oncolytic virotherapy has advanced since the days of its conception but therapeutic efficacy in the clinics does not seem to reach the same level as in animal models.
Markus Vähä-Koskela, Ari Hinkkanen
doaj   +4 more sources

Virus, Oncolytic Virus and Human Prostate Cancer

open access: yesCurrent Cancer Drug Targets, 2017
Prostate cancer (PCa), a disease, is characterized by abnormal cell growth in the prostate - a gland in the male reproductive system. Although older age and a family history of the disease have been recognized as the risk factors of PCa, the cause of this cancer remains unclear.
Liu, Guang Bin   +3 more
openaire   +6 more sources

Oncolytic Virus Immunotherapy [PDF]

open access: yes, 2022
Dear Readers, Oncolytic Viruses (OV) are self-propagating agents that can selectively induce the lysis of cancer cells while sparing normal tissues. OV-mediated cancer cell death is often immunogenic and triggers robust anticancer immune responses and ...
openaire   +2 more sources

Oncolytic Virus Immunotherapy [PDF]

open access: yesCancers, 2021
Oncolytic viruses (OVs) were originally developed as direct cytotoxic agents but have been increasingly recognised as a form of immunotherapy [...]
Marchini, Antonio   +2 more
openaire   +2 more sources

Arming vaccinia virus for pancreatic cancer oncolytic virotherapy [PDF]

open access: yes, 2011
PhDVaccinia virus is a 250-300nm enveloped DNA virus from the poxvirus family and is used as a vector for oncolytic viral gene therapy. No unique cell surface receptor has been identified for Vaccinia virus and the reasons for its tropism for cancer ...
Hiley, Crispin
core   +4 more sources

Assessment and development of adenovirus type 11 for cancer therapy [PDF]

open access: yes, 2010
PhDThe efficacy of oncolytic virotherapy is influenced by the interactions between the tumour, virus and host immunity. The first generation of oncolytic adenoviruses, based on serotype 5 (Ad5), has achieved limited success in clinical trials.
Wong, Han Hsi
core   +4 more sources

Development of a WNT-selective oncolytic adenovirus for imaging the therapy of colorectal cancers. [PDF]

open access: yes, 2008
PhDIntroduction: The concept of oncolytic adenoviruses has been validated in preclinical studies but clinical trials have demonstrated that the virus spread remains limited and the virus fails to infect all cancer cells in a tumour.
Peerlinck, Inge D. L.
core   +4 more sources

Measles Virus as an Oncolytic Immunotherapy [PDF]

open access: yesCancers, 2021
Measles virus (MeV) preferentially replicates in malignant cells, leading to tumor lysis and priming of antitumor immunity. Live attenuated MeV vaccine strains are therefore under investigation as cancer therapeutics. The versatile MeV reverse genetics systems allows for engineering of advanced targeted, armed, and shielded oncolytic viral vectors ...
Christine E. Engeland, Guy Ungerechts
openaire   +2 more sources

Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame [PDF]

open access: yes, 2012
Oncolytic influenza A viruses with deleted NS1 gene (delNS1) replicate selectively in tumour cells with defective interferon response and/or activated Ras/Raf/MEK/ERK signalling pathway.
Martin Michaelis   +32 more
core   +2 more sources

Suppression of CCDC6 sensitizes tumor to oncolytic virus M1

open access: yesNeoplasia: An International Journal for Oncology Research, 2021
Oncolytic virus is an effective therapeutic strategy for cancer treatment, which exploits natural or manipulated viruses to selectively target and kill cancer cells.
Ying Liu   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy